Companion Diagnostic Tests in Oncology Market Report

Global and Region Companion Diagnostic Tests in Oncology Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：140
  • REPORT CODE：GMM1003109
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Companion Diagnostic Tests in Oncology market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Companion Diagnostic Tests in Oncologymarket, defines the market attractiveness level of Companion Diagnostic Tests in Oncology market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Companion Diagnostic Tests in Oncology industry, describes the types of Companion Diagnostic Tests in Oncology market, the applications of major players and the market size, and deeply analyzes the current situation of the global Companion Diagnostic Tests in Oncology market and the development prospects and opportunities of Companion Diagnostic Tests in Oncology industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Companion Diagnostic Tests in Oncology market in Chapter 13.

    By Player:

    • Agilent

    • Thermo Fisher

    • Illumina

    • Genomic Health

    • QIAGEN

    • Agendia

    • Abbott

    • BioMerieux

    • Siemens Healthcare

    • Roche

    By Type:

    • Protein Detection

    • DNA Detection

    By End-User:

    • Pharmaceutical & Biotechnology Companies

    • Medical Device Companies

    • Research Institutes

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Companion Diagnostic Tests in Oncology Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Companion Diagnostic Tests in Oncology Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Companion Diagnostic Tests in Oncology Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Companion Diagnostic Tests in Oncology Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Companion Diagnostic Tests in Oncology Market Analysis and Outlook to 2022

    • 7.1 Global Companion Diagnostic Tests in Oncology Consumption (2017-2022)

    • 7.2 United States Companion Diagnostic Tests in Oncology Consumption (2017-2022)

    • 7.3 Europe Companion Diagnostic Tests in Oncology Consumption (2017-2022)

    • 7.4 China Companion Diagnostic Tests in Oncology Consumption (2017-2022)

    • 7.5 Japan Companion Diagnostic Tests in Oncology Consumption (2017-2022)

    • 7.6 India Companion Diagnostic Tests in Oncology Consumption (2017-2022)

    • 7.7 South Korea Companion Diagnostic Tests in Oncology Consumption (2017-2022)

    8 Region and Country-wise Companion Diagnostic Tests in Oncology Market Analysis and Outlook to 2028

    • 8.1 Global Companion Diagnostic Tests in Oncology Consumption Forecast (2022-2028)

    • 8.2 United States Companion Diagnostic Tests in Oncology Consumption Forecast (2022-2028)

    • 8.3 Europe Companion Diagnostic Tests in Oncology Consumption Forecast (2022-2028)

    • 8.4 China Companion Diagnostic Tests in Oncology Consumption Forecast (2022-2028)

    • 8.5 Japan Companion Diagnostic Tests in Oncology Consumption Forecast (2022-2028)

    • 8.6 India Companion Diagnostic Tests in Oncology Consumption Forecast (2022-2028)

    • 8.7 South Korea Companion Diagnostic Tests in Oncology Consumption Forecast (2022-2028)

    9 Global Companion Diagnostic Tests in Oncology Market Outlook by Types and Applications to 2022

    • 9.1 Global Companion Diagnostic Tests in Oncology Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Protein Detection Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global DNA Detection Consumption and Growth Rate (2017-2022)

    • 9.2 Global Companion Diagnostic Tests in Oncology Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medical Device Companies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)

    10 Global Companion Diagnostic Tests in Oncology Market Outlook by Types and Applications to 2028

    • 10.1 Global Companion Diagnostic Tests in Oncology Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Protein Detection Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global DNA Detection Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Companion Diagnostic Tests in Oncology Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Medical Device Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    11 Global Companion Diagnostic Tests in Oncology Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Companion Diagnostic Tests in Oncology Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Companion Diagnostic Tests in Oncology Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Companion Diagnostic Tests in Oncology Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Companion Diagnostic Tests in Oncology Market Competitive Analysis

    • 14.1 Agilent

      • 14.1.1 Agilent Company Details

      • 14.1.2 Agilent Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Agilent Companion Diagnostic Tests in Oncology Product and Service

    • 14.2 Thermo Fisher

      • 14.2.1 Thermo Fisher Company Details

      • 14.2.2 Thermo Fisher Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Thermo Fisher Companion Diagnostic Tests in Oncology Product and Service

    • 14.3 Illumina

      • 14.3.1 Illumina Company Details

      • 14.3.2 Illumina Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Illumina Companion Diagnostic Tests in Oncology Product and Service

    • 14.4 Genomic Health

      • 14.4.1 Genomic Health Company Details

      • 14.4.2 Genomic Health Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Genomic Health Companion Diagnostic Tests in Oncology Product and Service

    • 14.5 QIAGEN

      • 14.5.1 QIAGEN Company Details

      • 14.5.2 QIAGEN Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 QIAGEN Companion Diagnostic Tests in Oncology Product and Service

    • 14.6 Agendia

      • 14.6.1 Agendia Company Details

      • 14.6.2 Agendia Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Agendia Companion Diagnostic Tests in Oncology Product and Service

    • 14.7 Abbott

      • 14.7.1 Abbott Company Details

      • 14.7.2 Abbott Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Abbott Companion Diagnostic Tests in Oncology Product and Service

    • 14.8 BioMerieux

      • 14.8.1 BioMerieux Company Details

      • 14.8.2 BioMerieux Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BioMerieux Companion Diagnostic Tests in Oncology Product and Service

    • 14.9 Siemens Healthcare

      • 14.9.1 Siemens Healthcare Company Details

      • 14.9.2 Siemens Healthcare Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Product and Service

    • 14.10 Roche

      • 14.10.1 Roche Company Details

      • 14.10.2 Roche Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Roche Companion Diagnostic Tests in Oncology Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Companion Diagnostic Tests in Oncology

    • Figure Companion Diagnostic Tests in Oncology Picture

    • Table Global Companion Diagnostic Tests in Oncology Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Companion Diagnostic Tests in Oncology Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Companion Diagnostic Tests in Oncology Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Companion Diagnostic Tests in Oncology Consumption by Country (2017-2022)

    • Figure United States Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2017-2022)

    • Table Europe Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2017-2022)

    • Figure China Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2017-2022)

    • Figure Japan Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2017-2022)

    • Figure India Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2017-2022)

    • Figure South Korea Companion Diagnostic Tests in Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Companion Diagnostic Tests in Oncology Consumption Forecast by Country (2022-2028)

    • Figure United States Companion Diagnostic Tests in Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Companion Diagnostic Tests in Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Companion Diagnostic Tests in Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Companion Diagnostic Tests in Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Companion Diagnostic Tests in Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Companion Diagnostic Tests in Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Protein Detection Consumption and Growth Rate (2017-2022)

    • Figure Global DNA Detection Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Device Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Protein Detection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DNA Detection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Device Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Companion Diagnostic Tests in Oncology Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Companion Diagnostic Tests in Oncology Export by Region (Top 5 Countries) (2017-2028)

    • Table Agilent (Foundation Year, Company Profile and etc.)

    • Table Agilent Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Companion Diagnostic Tests in Oncology Product and Service

    • Table Thermo Fisher (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Companion Diagnostic Tests in Oncology Product and Service

    • Table Illumina (Foundation Year, Company Profile and etc.)

    • Table Illumina Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Companion Diagnostic Tests in Oncology Product and Service

    • Table Genomic Health (Foundation Year, Company Profile and etc.)

    • Table Genomic Health Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomic Health Companion Diagnostic Tests in Oncology Product and Service

    • Table QIAGEN (Foundation Year, Company Profile and etc.)

    • Table QIAGEN Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Companion Diagnostic Tests in Oncology Product and Service

    • Table Agendia (Foundation Year, Company Profile and etc.)

    • Table Agendia Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agendia Companion Diagnostic Tests in Oncology Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Companion Diagnostic Tests in Oncology Product and Service

    • Table BioMerieux (Foundation Year, Company Profile and etc.)

    • Table BioMerieux Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMerieux Companion Diagnostic Tests in Oncology Product and Service

    • Table Siemens Healthcare (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Companion Diagnostic Tests in Oncology Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Companion Diagnostic Tests in Oncology Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Companion Diagnostic Tests in Oncology Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US